Navigation Links
Emerging Opportunities in the US Enteric Diseases Diagnostic Testing Market 2016 - Profiles Key Suppliers and Potential Market Entrants Developing Innovative Technologies and Products
Date:10/28/2015

DUBLIN, Oct. 28, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7glfhh/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the US Enteric Diseases Diagnostic Testing Market" report to their offering.

About This Report

This new 322-page report presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs.

In addition to market share and sales forecasts, the report:

  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used for microbiology testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Companies Mentioned

  • Abbott Laboratories
  • AdnaGen/Alere
  • Agilent Technologies
  • Bayer Healthcare
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/7glfhh/2016_emerging

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
2. Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
3. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
4. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
5. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
6. The Emerging Eastern European Market For Interventional Cardiology Devices Will Grow To $282 Million By 2021
7. Frost & Sullivan Analyzes Emerging Opportunities for Stakeholders in the Transforming Healthcare Industry
8. Device Sector Facing Medical Education Challenges as Industry Continues Expansion into Emerging Markets
9. Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinsons Disease on Their Largest Commercial Plan
10. Emerging Markets Present Challenge for Medical Device Companies Outsourcing Clinical Activities
11. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2019)... ... November 15, 2019 , ... JustCBD looks forward to working ... Warriors was founded by the military families aboard Marine Corps Base Camp Lejeune, ... and their families. For the past 13 years, Hope For The Warriors has been ...
(Date:11/14/2019)... TAUNTON, Mass. (PRWEB) , ... November 14, 2019 ... ... to offering innovative green, natural, clean, safe, and effective products to health and ... “Deodorant Product of the Year” award. , The award is presented by the ...
(Date:11/14/2019)... ... November 14, 2019 , ... ... the earliest stages of disease development or their recurrence, is attracting interest and ... Research Institute), now part of Nuvance Health, and the Icahn School of Medicine ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate Therapeutics, Inc., ... diseases, announced it will have 5 poster presentations related to its medical devices ... for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/14/2019)... ... 14, 2019 , ... AstraZeneca and MSD (Merck) announced today ... status of its application for the MEK inhibitor selumetinib, for use in patients ... The FDA’s acceptance of the application is a major milestone for selumetinib becoming ...
(Date:11/12/2019)... , ... November 12, 2019 , ... AI for preventable ... KLAS report “Healthcare AI 2019 - Actualizing the Potential of AI”, which provides ... leader and the only healthcare-focused AI company with enough clients to complete a full ...
(Date:11/12/2019)... , ... November 12, 2019 , ... ... clinical study. With increasing site activation cycle times, extended contract negotiations and 80 ... is an area of clinical operations that’s ripe for improvement. Following an overview ...
(Date:11/11/2019)... ... ... Early praise for A Nurse’s Step-by-Step Guide to Publishing a Dissertation or DNP Project: ... and vital guidance for publishing dissertations or DNP projects. A Nurse’s Step-by-Step Guide to ... and will be shared with new graduates and colleagues alike.” , -Nancy White ...
Breaking Medicine News(10 mins):